The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
about
Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV InfectionsIL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disordersCytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of BrazilConstitutive release of IFNγ and IL2 from peripheral blood mononuclear cells of rhesus macaques (Macaca mulatta) infected with simian T-lymphotropic virus type 1.CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.CD4+ T cell subsets and Tax expression in HTLV-1 associated diseases.Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection.Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.IFNG +874A/T Polymorphism Among Asymptomatic HTLV-1-Infected Individuals Is Potentially Related to a Worse Prognosis.
P2860
Q26768628-64600D95-4CA2-4595-A895-1DFA99C71CB6Q34214760-92177ACE-FC90-4E5B-9625-A01E8EB0BD60Q34927431-5993611A-5DC5-4EF8-B7A7-183CA9D04BBDQ36334037-0AF7CDF6-2A5E-47BA-86DF-699D33E1097AQ37401051-32039E2D-93BF-435F-9001-DAC79C2E0596Q37579811-FA5A1319-41FE-42AC-A68C-8AC8C73F997DQ37726498-ABBF1F50-4AB3-4EE7-857D-15E4D812B59FQ38972538-F90345D0-BAA4-49B4-8DE6-3A641CB7FB74Q39319460-37055A58-F0FF-4765-80BB-A9941EF9686DQ39403386-3D883BAD-38F1-41A0-9D1B-F1D7ED2429A1Q39487416-01458A46-279C-461B-BEEB-AE4C2B397C1AQ50000058-6CA83EA4-5CDB-40E8-879F-E8F7D5015AF4Q54977276-E1B89EAE-0F6B-4F46-8911-1FC27B6BBBD3
P2860
The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The elevated interferon gamma ...... arker in HAM/TSP pathogenesis.
@en
The elevated interferon gamma ...... arker in HAM/TSP pathogenesis.
@nl
type
label
The elevated interferon gamma ...... arker in HAM/TSP pathogenesis.
@en
The elevated interferon gamma ...... arker in HAM/TSP pathogenesis.
@nl
prefLabel
The elevated interferon gamma ...... arker in HAM/TSP pathogenesis.
@en
The elevated interferon gamma ...... arker in HAM/TSP pathogenesis.
@nl
P2093
P2860
P1476
The elevated interferon gamma ...... arker in HAM/TSP pathogenesis.
@en
P2093
A C Penalva de Oliveira
A J da S Duarte
L M I Fukumori
P A Montanheiro
P2860
P304
P356
10.1111/J.1365-3083.2009.02291.X
P577
2009-10-01T00:00:00Z